Colorectal carcinomatosis: A new oncologic frontier

Current Opinion in Oncology

Volumn 17, Issue 4, 2005, Pages 397-399

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Colorectal cancer; Cytoreductive surgery; Hyperthermia; Intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; DOXORUBICIN PLUS CISPLATIN; MITOMYCIN C; MITOXANTRONE; UNCLASSIFIED DRUG;

CANCER SURVIVAL; CARCINOMATOSIS; CHEMOTHERAPY; COLORECTAL CARCINOMA; CYTOREDUCTIVE SURGERY; HUMAN; HYPERTHERMIA; ONCOLOGY; OPERATING ROOM; PRIORITY JOURNAL; REVIEW;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FORECASTING; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS;

EID: 21344445711     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000161746.32511.41     Document Type: Review

References (16)

1. Weiss L. Metastatic inefficiency. In Principles of metastases. Edited by Weiss L. Orlando: Academic Press; 1985. pp. 134-159.
2. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221: 29-42.
3. De Lima Vazquez V, Sugarbaker PH. Cholecystectomy, lesser omentectomy and stripping of the omental bursa, a peritonectomy procedure. J Surg Oncol 2003; 84:45-49.
4. De Lima Vazquez V, Sugarbaker PH. Total anterior parietal peritonectomy. J Surg Oncol 2003; 83:261-263.
5. De Lima Vazquez V, Sugarbaker PH. Xiphoidectomy. Gastric Cancer 2003; 6:127-129.
6. Van Ruth S, Verwaal VJ, Zoetmulder FAN. Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin North Am 2003; 12:771-780.
7. Elias DM, Sideris L. Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. Surg Oncol Clin North Am 2003; 12:755-769.
8. Mohamed F, Sugarbaker PH. Intraperitoneal taxanes. Surg Oncol Clin North Am 2003; 12:825-833.
9. De Bree E, Rosing H, Beijnen JH, et al. Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer. Anticancer Drugs 2003; 14:103-110.
10. Rossi CR, Mocellin S, Pilati P, et al. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surg Oncol Clin North Am 2003; 12:781-794.
11. Link KH, Roitman M, Holtappels M, et al. Intraperitoneal chemotherapy with mitoxantrone in malignant ascites. Surg Oncol Clin North Am 2003; 12:865-872.
12. Glehen O, Gilly FN, Sugarbaker PH. New perspectives in the management of colorectal cancer: what about peritoneal carcinomatosis? Scand J Surg 2003; 92:178-179.
13. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21.3737-3743.
14. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22:3284-3292. This multi-institutional retrospective study examined the results of treatment of 506 patients who had colorectal carcinomatosis. All patients were treated with cytoreductive surgery plus some form of perioperative intraperitoneal chemotherapy. The patients who had a complete cytoreduction had a 32.4-month median survival whereas the survival for this group of patients in historical controls is approximately 6 months. The study emphasizes that these treatments can be offered at a wide variety of institutions. As in many other publications, the determinate variable was complete cytoreduction; it was required for a long-term good result.
15. Petrelli NJ. Management of peritoneal surface malignancy (Forward). Surg Oncol Clin North Am 2003, 12:XIX-XX.
16. Yu W, Whang I, Young C, et al. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 2001; 25:985-990.